PARP inhibitors are a class of targeted drugs that block poly (ADP-ribose) polymerase enzymes involved in DNA repair, making them effective against cancers with specific genetic mutations such as BRCA1/2, commonly seen in breast and ovarian cancers. By preventing cancer cells from repairing DNA damage, PARP inhibitors promote cancer cell death. Treatment involves genetic testing and close monitoring for side effects like nausea, fatigue, and blood count changes.
2025 Bangkok Prices
PARP Inhibitor Therapy: THB 180,000–700,000 per treatment cycle
Includes genetic testing, drug administration, and patient monitoring
Offered at specialized oncology centers with expertise in genetic and precision medicine.